Transgene Biotek has informed that a meeting of Board of Directors of the Company will be held on Friday 29th May 2026. 1) To Consider and approve the Audited Financial Results (Standalone and consolidated) of the Company for the fourth quarter and financial year ended March 31, 2026. 2) Any Other Business matter, with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.